The rising price of naloxone-risks to efforts to stem overdose deaths

New England Journal of Medicine

Volumn 375, Issue 23, 2016, Pages 2213-2215

  Gupta, Ravi ^a   Shah, Nilay D ^d   Ross, Joseph S ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; MORPHINE; NALOXONE; OPIATE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

DRUG APPROVAL; DRUG COST; DRUG OVERDOSE; EMERGENCY HEALTH SERVICE; FOOD AND DRUG ADMINISTRATION; HUMAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; DRUG LEGISLATION; ECONOMICS; FEE; GOVERNMENT; MORTALITY; TRENDS; UNITED STATES;

ANALGESICS, OPIOID; DRUG COSTS; DRUG OVERDOSE; HEROIN; HUMANS; LEGISLATION, DRUG; NALOXONE; NARCOTIC ANTAGONISTS; PRESCRIPTION FEES; STATE GOVERNMENT; UNITED STATES;

EID: 85003434291     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1609578     Document Type: Review

References (5)

1. Wheeler E, Jones TS, Gilbert MK, Davidson PJ. Opioid overdose prevention programs providing naloxone to laypersons-United States, 2014. MMWR Morb Mortal Wkly Rep 2015; 64: 631-5.
2. Exploring naloxone uptake and use-a public meeting. Silver Spring, MD: Food and Drug Administration, July 1-2, 2015 (http//wwwfdagov/Drugs/NewsEvents/ucm442236 .htm).
3. Beletsky L, Rich JD, Walley AY. Prevention of fatal opioid overdose. JAMA 2012; 308: 1863-4.
4. Kapczynski A, Kesselheim AS. 'Government patent use': a legal approach to reducing drug spending. Health Aff (Millwood) 2016; 35: 791-7.
5. Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA 2016; 316: 858-71.